EUVIMEDEUVIMED entdecken
Crossref

SUPER-PANGENOMES FOR MEDICINAL PLANTS: EXPLOITING GENUS-WIDE GENOMIC FRAMEWORKS TO MINE RARE ALLELES AND DECODE SECONDARY METABOLITE DIVERSITY

Scientific Records · 25.06.2026 · 8

DOI: 10.62324/journal.sr/2026.062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scientific Records, online erschienen am 25.06.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The paradigm of the single reference genome that has been the mainstay of plant molecular genetics is fundamentally limited by the failure to capture the full diversity of genetic variation in a species or genus.This is especially consequential in the case of medicinal plants, the pharmaceutical usefulness of which directly relies on the remarkable diversity of secondary metabolites alkaloids, terpenoids, and phenolics which can differ significantly across accessions and wild relatives.The concept of super-pangenomics has become a game changer to this issue as it expands the pangenome concept at the species level to the genus level through systematic incorporation of genomes of cultivated species, landraces and wild relatives into primary, secondary and tertiary gene pools.It is built in these genus-scale genomic structures with long-read sequencing technology and graph-based bioinformatics that systematize the full repertoire of structural variants (SVs), presence/absence variation (PAV), and rare alleles which are systematically unobservable to single-reference measurements.This literature review draws a synthesis of the theoretical framework, construction strategies, and biological knowledge arising out of super-pangenome studies, and a roadmap is provided towards their implementation in high-priority medicinal plant genera.Crop super-pangenomes such as tomato, chickpea, rice, soybean and cotton, reliably display the enrichment of the dispensable and private genomic regions accessible only with such genus-wide resources with genes involved with specialized metabolism, stress response and phenotypic novelty.Even with significant progress in the sequencing technology and computational infrastructure, no published super-pangenome so far exists of any major medicinal plant genus.The barriers to these are the large, heterozygous, and often polyploid genomes of medicinally valuable taxa, compounded by access restrictions into germplasm, and lack of proven bioinformatic pipelines specific to these species.Panax, Cannabis, Artemisia, Salvia, and Papaver were also declared the priority targets of coordinated super-pangenome investment.This combination of these resources with the multi-omics data transcriptomics, metabolomics and proteomics will enable a systemslevel connection between genomic variation and chemotypic diversity to provide a scientific and biotechnological platform unmatched by any previous breeding or phytopharmaceutical discovery.

Zitieren

APA

(2026). SUPER-PANGENOMES FOR MEDICINAL PLANTS: EXPLOITING GENUS-WIDE GENOMIC FRAMEWORKS TO MINE RARE ALLELES AND DECODE SECONDARY METABOLITE DIVERSITY. Scientific Records, 8. https://doi.org/10.62324/journal.sr/2026.062

Vancouver

SUPER-PANGENOMES FOR MEDICINAL PLANTS: EXPLOITING GENUS-WIDE GENOMIC FRAMEWORKS TO MINE RARE ALLELES AND DECODE SECONDARY METABOLITE DIVERSITY. Scientific Records. 2026:8. doi:10.62324/journal.sr/2026.062

BibTeX
@article{euvimed2026,
  title = {SUPER-PANGENOMES FOR MEDICINAL PLANTS: EXPLOITING GENUS-WIDE GENOMIC FRAMEWORKS TO MINE RARE ALLELES AND DECODE SECONDARY METABOLITE DIVERSITY},
  journal = {Scientific Records},
  year = {2026},
  pages = {8},
  doi = {10.62324/journal.sr/2026.062}
}
Kostenlos starten →